Sutro Biopharma
STRO
STRO
123 hedge funds and large institutions have $118M invested in Sutro Biopharma in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 30
46% less capital invested
Capital invested by funds: $216M → $118M (-$98.8M)
Holders
123
Holding in Top 10
2
Calls
$243K
Puts
$67K
Top Buyers
| 1 | +$4.73M | |
| 2 | +$2.9M | |
| 3 | +$2.29M | |
| 4 |
BlackRock
New York
|
+$1.06M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$784K |
Top Sellers
| 1 | -$2.99M | |
| 2 | -$2.85M | |
| 3 | -$2.71M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.55M |
| 5 |
EP
Eversept Partners
New York
|
-$2.11M |